Pharmaceutical Executive
October 17, 2007
News Analysis
0
0
In a blockbuster codevelopment deal, GlaxoSmithKline gains rights to an innovative Phase III melanoma drug.
October 10, 2007
News Analysis
0
0
New Web site allows users to create tribute dolls for breast cancer survivors. For every doll made, AZ will donate $1 to charity.
March 14, 2007
News Analysis
0
0
Swiss drug maker gears up to launch first in class Tekturna.
April 26, 2006
News Analysis
0
0
A federal district court ruled that FDA cannot fail to rule on a Sandoz's application for approval of omnitrope, a human growth hormone, just because it has no policy for generic biologics. Court watchers say the decision may help other generic biologics move forward in the approvals process.
November 22, 2005
News Analysis
0
0
Log on to CrazyMeds.org. Find out what patients say about your drugs, and what they think doctors and pharma don’t tell them.